Ladenburg Thalmann Financial Services’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-370
Closed -$8K 5358
2019
Q2
$8K Sell
370
-1,110
-75% -$26.1K ﹤0.01% 4527
2019
Q1
$42K Hold
1,480
﹤0.01% 3519
2018
Q4
$36K Sell
1,480
-1,100
-43% -$29.6K ﹤0.01% 3487
2018
Q3
$96K Buy
+2,580
New +$69.6K ﹤0.01% 2853
2016
Q4
Sell
-18,100
Closed -$308K 4887
2016
Q3
$308K Buy
+18,100
New +$335K ﹤0.01% 1475
2016
Q2
Sell
-155
Closed -$3K 4783
2016
Q1
$3K Buy
+155
New +$2.97K ﹤0.01% 4258

Other funds holding IRMD

Ladenburg Thalmann Financial Services's IRMD Position: Q3 2019 in Review

Ladenburg Thalmann Financial Services sold out of iRadimed (IRMD) in Q3 2019, closing a stake of 370 shares — an estimated $8K sold.

Ladenburg Thalmann Financial Services first reported a position in IRMD in Q1 2016 and held it in 6 quarters. The position peaked at $308K in Q3 2016. 59 funds tracked by Wall St. Rank hold IRMD as of Q3 2019.

  • Ladenburg Thalmann Financial Services reported no remaining iRadimed position as of Q3 2019 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 370 iRadimed shares in Q3 2019, an estimated $8K.
  • Ladenburg Thalmann Financial Services first reported a position in iRadimed in Q1 2016 and held it in 6 quarters.
  • Ladenburg Thalmann Financial Services's iRadimed position peaked at $308K in Q3 2016.
  • 59 funds tracked by Wall St. Rank held iRadimed as of Q3 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q3 2019, filed 14 Nov 2019.